Skip to content
by Legal Desire
12 February 2025

Latham Advises on BioVersys’ CHF 213 Million IPO

Advising firms

Deal team

3 lawyers named
LawyerFirmSeniorityPracticeOffice
Ryan Benedict Lead Latham & Watkins LLP Partner corporate London
Irene Pistotnik Latham & Watkins LLP Not stated Capital Markets Milan
Alexandre Maturana Latham & Watkins LLP Associate Not stated Frankfurt

Stated terms

Stated value
CHF 213m (CHF 213 million)
What the figure measures
Total transaction value
Client
Not stated
Counterparties
BioVersys (Issuer)